Coverage of API manufacturers for Mycosis Fungoides marketed products
spanning across United States, Europe, China and India. The
manufacturers' details include manufacturers' name along with their
location.

This report provides a comprehensive understanding of the emerging Phase
III therapies for Mycosis Fungoides which can turn out to be future
prospective competitors for the marketed products. It will also put
light on the current market trends. Their forecasted global sales are
also provided till 2020.

Scope:

A review of the marketed products for Mycosis Fungoides including
their description, route of synthesis, egulatory milestones,
forecasted sales estimates till 2020 and API manufacturer details.